Our vision is to develop siRNA cell reprogramming for all major tissues implicated in complex disease.
Meet the Leadership Team
JOHN HOEKMAN
PhD, Co-founder & CEO
Founder, CSO, and CEO Impel Pharma. Brought his PhD invention to FDA approval for Trudhesa® for migraines. Inventor on >100 patents. PhD in Pharmaceutics at Univ. of Washington.
JANINE SENGSTACK
PhD, Co-founder & CSO
First to show repressing single transcription factor can reprogram gene expression to a healthy state. Hillblom Fellow. PhD in Cellular Aging at UCSF.
ROB CAHILL
Co-founder, COO & CBO
UCSF bioinformatics & machine learning. Founder & CEO at Jhana, acquired by FranklinCovey (NYSE: FC). EVP Product & Client Success at FranklinCovey. McKinsey. Stanford.
YI JIN
PhD, VP of siRNA Therapeutic Development
20 years of siRNA experience. Previously, Scientific Director of siRNA of Johnson & Johnson Innovative Medicine.
Our Team
CHARU REDDY
PhD, Principal Scientist, Preclinical
10+ years in metabolism and preclinical biotech. Postdoc at Harvard Medical School. PhD in rodent metabolism.
MOLLY KAEDING
Scientist, Early Discovery
Scientist roles at Nkarta, NASA, Stanford. MS/BS Biochemistry/Bio.
CARLEY HENDRIKS
Scientist, Early Discovery
RNA scientist. 18th employee at Mammoth Biosciences. BS Biochemistry.
L’ERIN MOORE
Scientist, Preclinical
10+ years of preclinical research at Gilead and Northwestern University.
SETH PAULSON
Software Engineer, RESET Platform
15 years of full-stack software development. Creator and lead developer at Biolearn, open source library for biomarkers of aging.
KATIE GJONI
PhD, Bioinformatics Data Scientist
Computational biologist with experience in ML pipeline development, genetic variant modeling and multi-omics. Prev. Genentech. PhD UCSF & Gladstone.
JIASHUN ZHENG
PhD, Bioinformatics Data Science (contract)
UCSF Professional Researcher. Collaborator, co-inventor and co-lead author
with Dr. Sengstack and Dr. Li.
HAO LI
PhD, Co-founder of Junevity & UCSF Professor
UCSF Prof. of Biochemistry & Biophysics. Director of UCSF Hillblom Center for Biology of Aging. Focus on cellular/molecular mechanisms of aging, human genetics, and bioinformatics.
Our Advisors
JOHN BAMFORTH
PhD, Former CMO at Eli Lilly
BRENT SAUNDERS
CEO Bausch + Lomb
REZA ABBASI ASL
PhD, UCSF Professor, Boinformatics & AI, Weill Institute for Neurosciences
JOHN NEWMAN
MD/PhD, Geriatrician and Professor of Metabolism at UCSF and The Buck Institute for Research on Aging
SAMUEL KLEIN
MD, Wash U Professor, Diabetes Research Center
AIMEE KAO
MD/PhD, UCSF Professor, Neurology, Memory & Aging Center
SCOTT FRIEDMAN
MD, Director, Mount Sinai Liver Research Institute
CARL DAMBKOWSKI
MD, Chief Medical Officer, Apogee Therapeutics
Our Investors
Junevity’s investors include Goldcrest Capital (lead), Godfrey Capital (lead), biotech veterans, doctors, tech entrepreneurs and hedge fund managers.
Global spend on healthcare due to age-related diseases exceeds $5 trillion annually. We can change this.
